Literature DB >> 11358847

Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.

B A Schmidt1, A Rose, C Steinhoff, T Strohmeyer, M Hartmann, R Ackermann.   

Abstract

Testicular germ cell tumors (GCT) characteristically display two chromosome 12 abnormalities: the isochromosome i(12p) and concomitant deletions of the long arm. Some genes important in the control of the G(1)-S cell cycle checkpoint G(1)-S, i.e., cyclin-dependent kinases 2 and 4, cyclin D2 are located on this chromosomal region. Therefore, testicular GCTs were analyzed as to the expression of CDK2, CDK4, CDK6, and the expression of their catalytic partners cyclins D1, D2 and E by semiquantitative reverse transcription-PCR. Cyclin D2, located on 12p, was overexpressed in 69% (31 of 45) of the tumors by a mean factor of 8, including all histological subtypes. In addition, the cyclin D2 partner CDK4 was increased in 41% (21 of 51) of all tumors by a factor of 6, most strongly in embryonal carcinomas. Sixty-four percent of the seminomas and 23% of the non-seminomas had decreased expression of CDK6 by a mean factor of 5 (P = 0.009). Statistical analysis using configural frequency analysis and regression analysis revealed that cyclin D2 and CDK4 expression were strongly correlated (r(2) = 0.682; P = 0.000052), whereas expression of CDK6 did not correlate with either of them (r(2) = 0.382; P = 0.00085). CDK2 and its catalytic partner cyclin E were down-regulated in 40% (19 of 47) and 42% (19 of 45) of the tumors, respectively, by a factor of 7 each. Western blots and immunohistochemical experiments confirmed cyclin D2 and CDK4 overrepresentation and reduced expression of cyclin E and CDK2 tumors in the few tumors under protein study. Despite its localization on 12q13, a hot spot for loss of heterozygosity in testicular GCTs (>40%), Southern blotting revealed no gross DNA alteration of the CDK2 gene. Because up-regulation of the cyclin D2/CDK4 complex and down-regulation of cyclin E/CDK2 complex were found in seminomas as well as in non-seminomas and in all tumor stages, these findings seem to be early events during tumorigenesis of testicular GCTS: Together with previous findings that retinoblastoma mRNA and protein expression is strongly decreased in these tumors, these data suggest an unusual deregulated G(1)-S checkpoint as a decisive event for germ cell tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358847

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Biological markers of cisplatin resistance in advanced testicular germ cell tumours.

Authors:  Adelaida García-Velasco; Ignacio Durán; Elena García; Miquel Tarón; Claudio Ballestín; Daniel Castellanos; Hernán Cortés-Funés; Luis Paz-Ares
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

2.  Recurrent cyclin D2 mutations in myeloid neoplasms.

Authors:  V Khanna; C A Eide; C E Tognon; J E Maxson; B Wilmot; D Bottomly; S McWeeney; D K Edwards V; B J Druker; J W Tyner
Journal:  Leukemia       Date:  2017-06-20       Impact factor: 11.528

3.  Catfish rhamnose-binding lectin induces G0/1 cell cycle arrest in Burkitt's lymphoma cells via membrane surface Gb3.

Authors:  Shigeki Sugawara; Changhun Im; Tasuku Kawano; Takeo Tatsuta; Yasuhiro Koide; Daiki Yamamoto; Yasuhiro Ozeki; Kazuo Nitta; Masahiro Hosono
Journal:  Glycoconj J       Date:  2016-10-28       Impact factor: 2.916

4.  Reduced spermatogonial proliferation and decreased fertility in mice overexpressing cyclin E in spermatogonia.

Authors:  Vasco Liberal; Maria P De Miguel; Martha Henze; Manuel Nistal; Steven I Reed
Journal:  Cell Cycle       Date:  2010-10-04       Impact factor: 4.534

Review 5.  [Genetics of testicular germ cell tumors].

Authors:  I Verdorfer
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

Review 6.  The stem cell identity of testicular cancer.

Authors:  Amander T Clark
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

Review 7.  Platinum-refractory germ cell tumors: an update on current treatment options and developments.

Authors:  Christoph Oing; Winfried H Alsdorf; Gunhild von Amsberg; Karin Oechsle; Carsten Bokemeyer
Journal:  World J Urol       Date:  2016-07-23       Impact factor: 4.226

8.  Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition.

Authors:  Etsuo Susaki; Keiko Nakayama; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

9.  Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.

Authors:  Rolf I Skotheim; Vera M Abeler; Jahn M Nesland; Sophie D Fosså; Ruth Holm; Urs Wagner; Vivi Ann Flørenes; Nina Aass; Olli P Kallioniemi; Ragnhild A Lothe
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

10.  Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.

Authors:  Majid Kheirollahi; Masoud Mehr-Azin; Naser Kamalian; Parvin Mehdipour
Journal:  Med Oncol       Date:  2010-01-14       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.